n-methyl-3,4-methylenedioxyamphetamine has been researched along with Achromatopsia in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Achromatopsia: Severely deficient color perception, typically with monochromacy and reduced visual acuity. The atypical form can include normal visual acuity with pseudomonochromacy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hulka, LM | 1 |
| Wagner, M | 1 |
| Preller, KH | 1 |
| Jenni, D | 1 |
| Quednow, BB | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Achromatopsia
| Article | Year |
|---|---|
Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine-Related | 2013 |